NMIC Bulletin Vol. 27 No. 1 Direct oral anticoagulants (DOACs)
Share
Print
22 March, 2021
Direct oral anticoagulants (DOACs)
Direct oral anticoagulants (DOACs) have different dose criteria depending on the specific indication
Dosing errors with DOACs can result in patient harm; under-dosing may increase the risk of embolic events, while over-dosing can result in an increased risk of bleeding
The patient’s age, weight, renal function and concomitant medication should be considered when selecting the dose of a DOAC for a specific indication
Clinically significant drug-drug interactions can occur with DOACs
